DSIP (Delta Sleep-Inducing Peptide) was first isolated from cerebral venous blood of rabbits in 1977. It is an amphiphilic nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) that has been extensively studied for its role in modulation of the sleep-wake cycle, hypothalamic-pituitary-adrenal (HPA) axis activity, and various neuroendocrine functions. Research indicates that DSIP promotes slow-wave (delta) sleep and interacts with stress-related hormonal pathways in animal models. It has also been studied for potential analgesic, anticonvulsant, and antioxidant effects. The product is provided as a lyophilized powder with high purity (≥98% by HPLC/MS) and includes full analytical documentation for research use only. DSIP is manufactured under GMP-aligned, ISO-compliant conditions to ensure quality and consistency. It is strictly for research applications and not intended for human use or therapeutic purposes.
DSIP (Delta Sleep-Inducing Peptide)
Price range: $52.00 through $86.00
DSIP (Delta Sleep-Inducing Peptide) is a synthetic research-grade neuropeptide studied for its effects on sleep regulation and stress response.
Additional information
| Weight | .125 lbs |
|---|---|
| Dimensions | 9 × 7 × .5 in |
| Size: No selection | 5mg, 10mg, 15mg |
Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.






